Cervical cancer is an important malignancy threatening the health of women that has been extensively studied lately due to its impressive anti-tumor and immunomodulatory experiences. Astragalus Polysaccharide (APS), also the primary active constituent of the traditional Chinese medicine Astragalus, is generally gaining immense attention because of its impressive anti-tumor and immunomodulatory properties. As part of the immune system APS both regulates the immune response and directly kills tumor cells: it triggers tumor cell apoptosis and remodels the immune microenvironment to augment the immune response, thereby complementing each other in fighting the tumor. Also, it can affect ERS signaling pathway and enable the reversal of epithelial-mesenchymal transition (EMT) process, inhibition of tumor invasion and metastasis, as well as the increase of the sensitivity of chemotherapy drugs. This paper examines the mechanism of synergy of APS in directly killing tumor cells, multifaceted immune control, and chemosensitization, which have the great potential to help in an adjunct therapy of cervical cancer, provides a theoretical background of development of the new treatment methods, as well states the single shortcoming of clinical application due to the absence of standardized portocol.
Research Article
Open Access